Inspire Medical Systems, Inc. $INSP Shares Newly Purchased by Jefferies Financial Group Inc.

Jefferies Financial Group Inc. acquired a new stake in Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) during the 3rd quarter, Holdings Channel.com reports. The firm acquired 23,428 shares of the company’s stock, valued at approximately $1,625,000.

Other large investors have also bought and sold shares of the company. EverSource Wealth Advisors LLC grew its holdings in Inspire Medical Systems by 1,115.4% during the 1st quarter. EverSource Wealth Advisors LLC now owns 632 shares of the company’s stock worth $33,000 after acquiring an additional 580 shares during the period. Sterling Capital Management LLC boosted its stake in Inspire Medical Systems by 450.6% during the 3rd quarter. Sterling Capital Management LLC now owns 914 shares of the company’s stock worth $63,000 after acquiring an additional 748 shares during the last quarter. Versant Capital Management Inc boosted its stake in Inspire Medical Systems by 379.0% during the 2nd quarter. Versant Capital Management Inc now owns 958 shares of the company’s stock worth $43,000 after acquiring an additional 758 shares during the last quarter. Pinnacle Wealth Planning Services Inc. grew its holdings in shares of Inspire Medical Systems by 19.8% in the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 1,172 shares of the company’s stock valued at $81,000 after buying an additional 194 shares during the period. Finally, Nisa Investment Advisors LLC increased its holdings in shares of Inspire Medical Systems by 68.5% in the third quarter. Nisa Investment Advisors LLC now owns 1,200 shares of the company’s stock worth $83,000 after acquiring an additional 488 shares in the last quarter. 94.91% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have commented on INSP shares. Oppenheimer upgraded shares of Inspire Medical Systems from a “market perform” rating to an “outperform” rating and set a $85.00 target price on the stock in a report on Tuesday, August 4th. Royal Bank Of Canada increased their price target on Inspire Medical Systems from $60.00 to $75.00 and gave the company a “sector perform” rating in a research note on Thursday, October 1st. Barclays reduced their target price on shares of Inspire Medical Systems from $65.00 to $62.00 and set an “underweight” rating for the company in a research report on Tuesday, November 3rd. Wells Fargo & Company boosted their price target on Inspire Medical Systems from $56.00 to $69.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 3rd. Finally, UBS Group initiated coverage on Inspire Medical Systems in a research note on Tuesday, July 28th. They set a “sell” rating and a $39.00 target price for the company. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, twelve have given a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $71.24.

Get Our Latest Stock Analysis on Inspire Medical Systems

Inspire Medical Systems Stock Performance

Inspire Medical Systems stock opened at $61.16 on Monday. The firm has a market cap of $1.77 billion, a price-to-earnings ratio of 17.78, a PEG ratio of 4.47 and a beta of 0.67. The firm has a 50 day moving average price of $68.94 and a two-hundred day moving average price of $57.69. Inspire Medical Systems, Inc. has a 52-week low of $38.91 and a 52-week high of $147.03.

Inspire Medical Systems (NYSE:INSP – Get Free Report) last issued its quarterly earnings results on Monday, November 2nd. The company reported $0.14 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.05. The firm had revenue of $206.69 million during the quarter, compared to the consensus estimate of $204.31 million. Inspire Medical Systems had a return on equity of 7.32% and a net margin of 11.43%. The business’s revenue was down 7.9% compared to the same quarter last year. During the same period last year, the business posted $0.38 EPS. As a group, equities research analysts predict that Inspire Medical Systems, Inc. will post 1.29 EPS for the current fiscal year.

Inspire Medical Systems Company Profile

(Free Report)

Inspire Medical Systems is a medical technology company focused on treatments for obstructive sleep apnea, a condition in which breathing repeatedly stops or becomes restricted during sleep. Founded in 2007 and based in Minnesota, the company develops implantable devices intended for certain patients who cannot use or benefit from conventional positive airway pressure therapy. Its primary product, the Inspire Upper Airway Stimulation system, uses an implanted device to monitor breathing and deliver mild stimulation to the hypoglossal nerve, helping keep the airway open during sleep.

Further Reading

Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP – Free Report).

Institutional Ownership by Quarter for Inspire Medical Systems (NYSE:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.